Live·Verified funding discovery · 2026.2
874 grants · 19 open · 435 companies · 2640 concepts874 / 19 / 435 / 2640
△COMPANIESCompanies rated · 435 (no change)△PROJECTSProjects rated · 70 (no change)△CATALOGUE874 grants in catalogue · 19 open right now•POWERED BYOpen Longevity · 501(c)(3) · Sherman Oaks, CA△COMPANIESCompanies rated · 435 (no change)△PROJECTSProjects rated · 70 (no change)△CATALOGUE874 grants in catalogue · 19 open right now•POWERED BYOpen Longevity · 501(c)(3) · Sherman Oaks, CA
← Back to Eternal Search
Daniel J. Anderson

Daniel J. Anderson

individual
Ecosystem influencer

About

Daniel J. Anderson, Ph.D. is a biotechnology R&D executive focused on drug discovery and translational science. In January 2026, he was appointed Chief Scientific Officer of Integrated Biosciences, where he leads scientific strategy for small-molecule therapeutics targeting age-related diseases. Previously, he served as CSO at Eikon Therapeutics and held biology leadership roles at Recursion Pharmaceuticals, Cleave Biosciences, and Genentech.

Areas of interest

longevitybiotechdrug discoveryaging biologytranslational researchsynthetic biologyartificial intelligence